Über uns

À propos de nous

Nachhaltigkeit

Durabilité

Open Access

Karriere

Carrière

Datenschutz

Protection des données

Impressum

Mentions légales

Zahlung und Lieferung

Paiement et livraison

LEXIA

LEXIA Arbeitsrecht

Was ist LEXIA?

C'est quoi LEXIA ?

LEXIA Familienrecht

Zeitschriften

Revues

recht

Pflegerecht

ZBJV

forumpoenale

ZStrR

Anwaltsrevue

Revue de l'avocat

RSAS

FamPra.ch

ASYL

Life Science Recht

BlAR

Sachbuch

Livres spécialisés

LOKI

Semaphor

Fokusthemen

Focus

Thema

Recht studieren

Arbeitsrecht

Droit du travail

Studium

Études

Familienrecht

Droit de la famille

Sozialversicherungsrecht

Droit des assurances sociales

Strafrecht

Droit pénal

Publikationen

Publications

Literatur

Onlinemodule LEXIA

Modules en ligne LEXIA

Bücher

Livres

Buchreihen

Collections

Datenbanken

recht.ch

Studienliteratur

Littérature pour les études

Services

Dienstleistungen für

Corporate Books

Publishing Lösungen

Aktuelles

Geschäftskunden

Professionnels

Corporate Publishing

Content solutions

Buchhandlungen

Librairies

Veranstaltungen

Événements

Presse

Dozierende

Enseignants

Studierende

Étudiants

Inserierende

Annonceurs

Newsletter

Blog

Autorinnen/Autoren

Auteurs

Unsere Schreibenden

Hilfe

Unsere Autorinnen und Autoren

Liste

Autorenlounge

Espace des auteurs

Bei uns publizieren

Publier chez nous

Autorenstimmen

Témoignages

Verlag

Éditions

Themen

Mehr wissen

Mitarbeitende

Collaborateurs

Geschichte

Histoire

Vision und Mission

Vision et mission

Unser Magazin

Notre magazine

Unternehmenskultur

Culture d'entreprise

Partner

Partenaires

Kontakt

Contact

Shop

Schweizer Recht

Ausländisches Recht

Über unseren Shop

Neuerscheinungen

Nouveautés

Unsere Funktionen

Nos fonctions

Vorankündigungen

À paraître

Nach Rechtsgebiet

Par domaine juridique

Kommentare

Commentaires

Gesamtkatalog

Catalogue complet

Law and Criminology (R0)

Elisabeth Anna Lümkea Andersen

Regulation of Biotechnological Risks in a Multi-Level System

An Analysis of the EU Regulation of Genome Edited Plants in light of WTO Law and CETA

&lt;p&gt;Introduction.- Scientific Background.- The European Court of Justice&amp;rsquo;s Decision on Genome Editing.- The Regulation of Genetically Modified Plants in the European Union.- The EU&amp;rsquo;s Obligations under WTO law and CETA.- EU Regulations on Genome Edited Plants under WTO Law and CETA.- The Future of Genome Edited Plants in the EU.- Concluding Remarks.- Summary of Results.&lt;/p&gt;

Economics, Law, and Institutions in Asia Pacific

The rules-based international economic order is undergoing profound transformation. Geopolitical risk and geoeconomic strategy are no longer external shocks to a stable system; they now shape the core of international economic law (IEL), influencing trade regulation, investment protection, digital governance, and supply-chain design. Tariffs, sanctions, investment screening, data controls, and security-driven regulation have become structural features of the global economy.This edited volume originates from the 9th Asian International Economic Law Network (AIELN) Conference, held in Tokyo in June 2025 under the theme “Geopolitical Risks and Geoeconomics in International Economic Law: Asian Perspectives and Beyond.” It brings together scholars, practitioners, and policymakers to examine how IEL is responding to persistent geopolitical uncertainty and regulatory risk.The chapters analyze how legal frameworks allocate the costs of geopolitical and regulatory risk, whether the liberal trading system is fragmenting into regional or minilateral arrangements, and how security, resilience, and sustainability are reshaping market access and investment governance. A central question is whether international economic law can adapt to these pressures without abandoning rule-based multilateralism.Placing Asia at the center of the analysis, the volume explores whether Asian states can move beyond being objects of great-power strategies and instead act as norm entrepreneurs shaping the future of international economic law.

Asian Perspectives and Beyond

Geopolitical Risks and Geoeconomics in International Economic Law

Woodhead Publishing Series in Biomaterials

Engineered Biomaterials for Drug Delivery covers a core selection of engineering approaches and methods to optimize materials for drug delivery, including grafting, cross-linking, thiolation, conjugation, and the functionalization of biomaterials. A wide range of engineered biomaterial types are described, from biopolymers and nanobiomaterials, to metals, ceramics, and composites. Biocompatibility, toxicity, and regulatory considerations are also thoroughly discussed, ensuring the reader is fully equipped for efficient biomaterials selection and utilization in drug delivery applications. This is a must-have reference for those working in the fields of materials science, biomedical engineering, pharmaceutical science, pharmacology, chemical engineering, and clinical science.

Engineered Biomaterials for Drug Delivery

Springer Textbooks in Law

Competition Law – Digital Markets Act – Platform Regulation

Digital Competition Law

Advances in Medical Imaging: From Behavioral Analysis to Disease Prevention and Rehabilitation presents a comprehensive exploration of the rapidly evolving field of medical imaging at the crossroads of clinical science, behavioral research, and public health. This book addresses the growing need to understand how advanced imaging technologies-such as MRI, PET, and ultrasound-are transforming healthcare beyond traditional diagnosis. By capturing structural, functional, metabolic, and molecular processes, these innovations provide new insights into brain function, lifestyle impacts, chronic disease, and rehabilitation, supporting the shift toward personalized and preventive medicine. The book is organized into five thematic sections covering a wide range of topics. Early chapters focus on the integration of neuroimaging with behavioral science, highlighting brain-behavior relationships through cutting-edge imaging modalities and cognitive software. Subsequent sections examine the effects of sedentary lifestyles on brain health, vascular function assessed by ultrasound, and musculoskeletal aging through imaging biomarkers. Additional chapters explore chronic disease management, yoga and cognitive well-being, stroke recovery, traumatic brain injury rehabilitation, and the expanding role of imaging in oncology and systemic diseases. Throughout, the book emphasizes the use of artificial intelligence, radiomics, and multimodal imaging to enhance precision medicine and population health research. Advances in Medical Imaging: From Behavioral Analysis to Disease Prevention and Rehabilitation offers valuable insights for researchers, clinicians, and healthcare professionals interested in the applications of medical imaging across multiple disciplines. It highlights imaging’s critical role in advancing personalized care, supporting preventive strategies, and fostering innovation in modern healthcare.

From Behavioral Analysis to Disease Prevention and Rehabilitation

Advances in Medical Imaging

This book studies how international law is evolving to meet the challenges of the digital age. This book tries to answer this question by presenting a detailed analysis of how international law is responding or failing to respond to the digital economy.

The author investigates how leading countries with advanced digital economic systems, including the regulation of cryptocurrencies or digital trade and E-commerce in the European Union, China, and USA, have approached these issues. Taking the WTO and the UN as examples, the book examines the efforts made by these international institutions to retrofit traditional legal structures for a world increasingly defined by the internet. Can global trade rules designed for physical goods be applied to digital products and services? How can global institutions facilitate cooperation between countries with drastically different levels of technological development? These questions shape the discussion.

The approach used in this book does not only focus on the laws but also the growing technological world. The digital world is more dynamic than it is possible to regulate it through laws that may take a lot of time to be adopted and enforced. Some laws were drafted many years ago and may now be incomplete and full of loopholes and ambiguities. By mixing legal research with real-world examples, this book aims to provide practical insights into how international law can progress to address these issues at the front. This book provides the reader with a valuable understanding of the digital economy and its relationship with international law by integrating comparative legal analysis with insights regarding contemporary global economic conditions. The author has looked at laws and regulations, examined case studies, and critically assessed how international law might (or might not) be the solution to the challenges of globalization in the digital age.

Exploring the New Horizons of International Law Concerning Globalization of Economy

Agentic Systems for Smarter Medicine

Self-Learning AI in Healthcare

Chapter 1 Biotechnology the Science.- Chapter 2 Commercial Application of Biotechnology.- Chapter 3 Law and Policy of Biotechnology.- Chapter 4 IPR and Biotechnology.- Chapter 5 Trade and Environmental regulation of Biotechnology.- Chapter 6 Human Rights and Biotechnology.- Chapter 7 Biotechnology and Society.- Chapter 8 Bio-piracy and Bio-Prospecting.- Chapter 9 Regulation of Biotechnology.

Perspectives from USA, UK, EU and India

Law Relating to Biotechnology, 2nd Ed

Accounting, Finance, Sustainability, Governance & Fraud: Theory and Application

This book examines the field of financial cooperation and regulation along the Belt and Road. By evaluating the relevant theories, investigating the different sectors and analysing the practices of the individual country case studies, the book presents a well-rounded portrait of the topic.&nbsp; &nbsp; &nbsp;The book draws from experiences of different jurisdictions and provides a thorough and comprehensive study of different sectors, such as banking, bond, transportation finance, professionals, and others. The&nbsp;chapter authors’ in-depth experience provides both an academic's and practitioner’s view into the variety of topics explored.&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;This book is beneficial to undergraduate and postgraduate students, academics, financial professional, as well as law enforcement agencies and financial regulators who are interested in financial regulatory issues that have arisen as a result of China's Belt and Road Initiative.

Along the Belt and Road

Financial Cooperation and Regulation

Sustainability in Latin America: A Bioeconomic Approach explores the bioeconomy through theories, methodologies, and case studies rooted in specific contexts across Latin America. Rather than attempting to compile or generalize a singular vision of a Latin American bioeconomy, it highlights diverse experiences that reflect the region’s complexity. By its very nature, the bioeconomy is both multidisciplinary and interdisciplinary. Accordingly, the book features contributions from various fields, offering a rich, multifaceted understanding of bioeconomic practices. For instance, Chapter 1 revisits Georgescu-Roegen’s theory through a fresh lens, enriched by new multidisciplinary insights into territorial and sociocultural dynamics. This approach opens up possibilities for rethinking consumption patterns, fostering sustainable technologies, and strengthening community development.

A Bioeconomic Approach

Sustainability in Latin America

China Arbitration Yearbook

This series of book includes the latest cases, materials and commentaries concerning arbitration from Supreme People's Court of PRC and other courts, the main arbitration institutions and the leading experts in China.Apart from introducing cases and material of main and recent development of arbitration in China, this series may also include reports or commentaries by experts. By offering guidance on what to do and how to proceed in practical scenarios, this book serves as a resource for the arbitration community, particularly for those involved in cases related to China. The exploration of practical applications and theoretical advancements will be especially appealing to practitioners and scholars in the field.The book meets the needs of the practitioners, arbitrators or academics who are interested in China arbitration. For the practitioners, it will benefit them in each stage of arbitration. For arbitrators, knowing the opinions, defenses and decisions will help them to handle the arbitration more effectively and successfully. For academics, the series of book is also an excellent source of analysis on China arbitration and all relevant judicial practice. Alongside this, for the business community and legal consultants, before doing business or providing legal consultation, they may need to know more about arbitration as alternative to litigation in China.

China Arbitration Yearbook (2024)

Durch die Genomeditierung mit der Genschere CRISPR/Cas und den Einsatz künstlicher Intelligenz bei der Analyse genetischer Daten erleben wir eine neue Dimension der Gentechnik. Wir sind die Generation mit der Genschere. Die Ergebnisse reichen von blutdrucksenkenden Tomaten und Gentherapien gegen Krebs über die Schaffung bakterieller Chassis als molekulare Werkstätten bis hin zur Wiedergeburt des ausgestorbenen Schattenwolfs und der ersten (Er)Zeugung von Designer-Babys.

Wie weit dürfen wir gehen? Gehört unsere Zukunft der Genomarchitektur? Brauchen wir Gentechnik, um den Herausforderungen des Klimawandels zu begegnen? Rettet uns künstliche Intelligenz vor einer genetischen Datenflut – oder macht sie Gesundheit und Therapie zu einer unverständlichen Blackbox?
Neue genomische Techniken ermöglichen präzise Eingriffe in das Erbgut – ganz ohne erkennbare Spuren. Sie basieren auf unserem wachsenden Verständnis von Genen, deren Bausteinen, epigenetischen Faktoren und Funktionen. Besonders in der Pflanzenzüchtung finden sie zunehmend Anwendung.

Dieses Buch vermittelt anschaulich und verständlich die Entwicklung der modernen Gentechnologie. Es lädt dazu ein, ethische, gesellschaftliche und rechtliche Fragen zu diskutieren.

Neu in dieser Auflage: Das Kapitel Gene und Gesetze beleuchtet die rechtlichen Rahmenbedingungen der Gentechnik in Züchtung und Medizin. Das Thema künstliche Intelligenz wurde erweitert, andere Kapitel wurden aktualisiert.

Wie CRISPR und KI unser Leben verändern

Gentechnik im Wandel

NEW YORK TIMES BESTSELLER • An explosive, deeply reported exposé of Johnson &amp; Johnson, one of America’s oldest and most trusted pharmaceutical companies—from an award-winning investigative journalist “A damning portrait.”—Associated Press “A page-turning drama that raises life-or-death questions about the world’s largest healthcare conglomerate.”—Jonathan Eig, Pulitzer Prize–winning author of King: A Life FINALIST FOR THE NATIONAL BOOK CRITICS CIRCLE AWARD AND THE LOS ANGELES TIMES BOOK PRIZE • A CHICAGO PUBLIC LIBRARY AND NEW YORK PUBLIC LIBRARY BEST BOOK OF THE YEAR One day in 2004, Gardiner Harris, a pharmaceutical reporter for The New York Times, was early for a flight and sat down at an airport bar. He struck up a conversation with the woman on the barstool next to him, who happened to be a drug sales rep for Johnson &amp; Johnson. Her horrific story about unethical sales practices and the devastating impact they’d had on her family fundamentally changed the nature of how Harris would cover the company—and the entire pharmaceutical industry—for the Times. His subsequent investigations and ongoing research since that very first conversation led to this book—a blistering exposé of a trusted American institution and the largest healthcare conglomerate in the world. Harris takes us light-years away from the company’s image as the child-friendly “baby company” as he uncovers reams of evidence showing decades of deceitful and dangerous corporate practices that have threatened the lives of millions. He covers multiple disasters: lies and cover-ups regarding the link of Johnson’s Baby Powder to cancer, the surprising dangers of Tylenol, a criminal campaign to sell antipsychotics that have cost countless lives, a popular drug used to support cancer patients that actually increases the risk that cancer tumors will grow, and deceptive marketing that accelerated opioid addictions through their product Duragesic (fentanyl) that rival even those of the Sacklers and Purdue Pharma. Filled with shocking and infuriating but utterly necessary revelations, No More Tears is a landmark work of investigative journalism that lays bare the deeply rooted corruption behind the image of babies bathing with a smile.

The Dark Secrets of Johnson & Johnson

No More Tears

Regulation of Biotechnological Risks in a Multi-Level System

Autres titres sur ce thème